SCHEMBL446743

SCHEMBL446743

CN1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620964 1.00
Hydrochloric Acid SCHEMBL1190430 0.97
SCHEMBL2760285 0.90
SCHEMBL18072564 0.88 SOS1 (0.34)
SCHEMBL20706020 0.88 SOS1 (0.34)
SCHEMBL17067231 0.88 SOS1 (0.34)
SCHEMBL1665473 0.88
SCHEMBL17067163 0.88 SOS1 (0.34)
SCHEMBL16070318 0.88
SCHEMBL17067233 0.88 SOS1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137650-A1 MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) 11949098 CANADA INC (CA) 2026-05-21 US claimed
EP-4709383-A1 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 Canada Inc. (CA) 2026-03-18 EP claimed
WO-2025097247-A1 METHOD OF TREATMENT OF FIBROSIS WITH INVERSE AGONIST OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2025-05-15 WO claimed
CN-119433616-A Preparation and application of polybenzimidazole anion exchange membrane capable of regulating hydrophilic and hydrophobic side chains 西南科技大学 2025-02-14 CN claimed
WO-2024229569-A9 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2025-01-30 WO claimed
WO-2024229569-A1 INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) 11949098 CANADA INC. (CA) 2024-11-14 WO claimed
CN-118496619-A Preparation method and application of quaternized polyether-ether-ketone anion exchange membrane 西南科技大学 2024-08-16 CN claimed
US-20220000864-A1 MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs) 11949098 CANADA INC. (CA) 2022-01-06 US claimed
EP-3883929-A1 4,5,6,7-TETRAHYDRO-L-BENZOTHIOPHENE MODULATORS OF RETINOIC ACID RECEPTOR RELATED (RAR) ORPHAN NUCLEAR RECEPTORS (RORS) 11949098 Canada Inc. (CA) 2021-09-29 EP claimed
CN-113166130-A 4,5,6, 7-tetrahydro-L-benzothiophene modulators of retinoic acid receptor-associated (RAR) orphan nuclear receptors (ROR) 11949098加拿大股份有限公司 2021-07-23 CN claimed
WO-2008114009-A1 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CAMBRIDGE ENTERPRISE LTD. (GB) 2008-09-25 WO claimed
WO-2008032064-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2008-03-20 WO claimed
WO-2008032086-A1 2-BENZIMIDAZOLYL-6-MORPHOLINO-4-PHENYLPYRIMIDINE DERIVATIVES AS PI3K AND MTOR INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-03-20 WO claimed
WO-2005105777-A1 SUBSTITUTED THIOPHENE AMIDE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA & UPJOHN COMPANY LLC (US) 2005-11-10 WO claimed
US-6169180-B1 NEW ECONOMICAL AND SIMPLE PROCESS, USING NEW INTERMEDIATE COMPOUND, FOR THE PRODUCTION OF 3'-SUBSTITUTED 7-AMINO-3-PROPENYL-4-CEPHEM-CARBOXYLIC ACID DERIVATIVES BIOCHEMIE GESELLSCHAFT (AT) 2001-01-02 US claimed
US-5644052-A MULTISTAGE REACTION TO PRODUCE CEPHALOSPORINS AND CHEMICAL INTERMEDIATES BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1997-07-01 US claimed
EP-0449191-B1 2-(Substituted pyrrolidinylthio)carbapenem derivatives BANYU PHARMA CO LTD (JP) 1996-07-03 EP claimed
US-5438054-A Antibacterial agent BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US claimed
WO-1991014687-A1 2-(SUBSTITUTED PYRROLIDINYLTHIO)CARBAPENEM DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1991-10-03 WO claimed
EP-0449191-A1 2-(Substituted pyrrolidinylthio)carbapenem derivatives Banyu Pharmaceutical Co., Ltd. (JP) 1991-10-02 EP claimed